Literature DB >> 6991426

Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes.

P Ferrieri, B Burke, J Nelson.   

Abstract

Group B streptococcal strains, representing the five major serotypes, were inoculated into infant rats by intranasal, oral, and intraperitoneal routes. Bacteremia regularly followed injection by the intraperitoneal route. Four strains (three of type III) isolated from human cerebrospinal fluid appeared more virulent for 5-day-old rats. Injection of fewer than 10 colony-forming units of one strain, a type III, led to bacteremia and death in 27% of animals. The cumulative bacteremia and mortality rate with this strain was 66% in animals given inocula of less than 10 to 10(3) colony-forming units. Bacteremia developed by 24 to 48 h with concentrations of greater than 10(5) colony-forming units per ml of blood, and death occurred soon afterward. Among bacteremic animals, positive cerebrospinal fluid cultures were found in 97%, and cerebrospinal fluid bacterial concentrations were equal to or exceeded bacterial counts in blood. The susceptibility of infant rats to infection with type Ia, Ic, or III strains was age dependent. Histopathological studies of the brain and meninges in 34 bacteremic animals with culture-positive cerebrospinal fluid revealed that 5- to 10-day-old animals had numerous bacteria distributed in a perivascular pattern but, with one exception, no leukocytic infiltration. In contrast, three of the 11- to 12-day-old and two 15-day-old animals had very thickened meninges infiltrated with polymorphonuclear leukocytes, macrophages, and bacteria.

Entities:  

Mesh:

Year:  1980        PMID: 6991426      PMCID: PMC550875          DOI: 10.1128/iai.27.3.1023-1032.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

2.  Group B beta-hemolytic streptococcal infection in the newborn. I. Early onset infection.

Authors:  J Quirante; R Ceballos; G Cassady
Journal:  Am J Dis Child       Date:  1974-11

3.  Haemophilus influenzae meningitis in infant rats after intranasal inoculation.

Authors:  E R Moxon; A L Smith; D R Averill; D H Smith
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Transmission of group B streptococci among parturient women and their neonates.

Authors:  C J Baker; F F Barrett
Journal:  J Pediatr       Date:  1973-12       Impact factor: 4.406

5.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants.

Authors:  C J Baker; F F Barrett; R C Gordon; M D Yow
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

6.  Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid.

Authors:  E R Moxon; P T Ostrow
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

7.  Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

Authors:  R S Baltimore; D L Kasper; C J Baker; D K Goroff
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

8.  Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women.

Authors:  M S Badri; S Zawaneh; A C Cruz; G Mantilla; H Baer; W N Spellacy; E M Ayoub
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

9.  Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation.

Authors:  A L Smith; D H Smith; D R Averill; J Marino; E R Moxon
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

10.  New approaches for the laboratory recognition of M types of group A streptococci.

Authors:  J Rotta; R M Krause; R C Lancefield; W Everly; H Lackland
Journal:  J Exp Med       Date:  1971-11-01       Impact factor: 14.307

View more
  33 in total

Review 1.  Escherichia coli translocation at the blood-brain barrier.

Authors:  K S Kim
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 2.  Recent advances in understanding the molecular basis of group B Streptococcus virulence.

Authors:  Heather C Maisey; Kelly S Doran; Victor Nizet
Journal:  Expert Rev Mol Med       Date:  2008-09-22       Impact factor: 5.600

3.  Entry and intracellular survival of group B streptococci in J774 macrophages.

Authors:  P Valentin-Weigand; P Benkel; M Rohde; G S Chhatwal
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

4.  Ring-enhancing lesions in neonatal meningitis: an analysis of neuroradiology pitfalls through exemplificative cases and a review of the literature.

Authors:  Mario Ganau; Kshitij Mankad; Uma Rami Srirambhatla; Zubair Tahir; Felice D'Arco
Journal:  Quant Imaging Med Surg       Date:  2018-04

Review 5.  Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.

Authors:  Mazen M Jamil Al-Obaidi; Mohd Nasir Mohd Desa
Journal:  Cell Mol Neurobiol       Date:  2018-08-16       Impact factor: 5.046

Review 6.  Defense at the border: the blood-brain barrier versus bacterial foreigners.

Authors:  Nina M van Sorge; Kelly S Doran
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

7.  Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid.

Authors:  Kelly S Doran; Erin J Engelson; Arya Khosravi; Heather C Maisey; Iris Fedtke; Ozlem Equils; Kathrin S Michelsen; Moshe Arditi; Andreas Peschel; Victor Nizet
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

8.  Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.

Authors:  Y H Tsai; M Bies; F Leitner; R E Kessler
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

9.  Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Authors:  N R Payne; Y K Kim; P Ferrieri
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

10.  Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci.

Authors:  A S Bayer; J O Morrison; K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.